Peptide heterodimers for molecular imaging

Amino Acids

Volumn 41, Issue 5, 2011, Pages 1081-1092

  Yan, Yongjun ^a   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Heterodimer; Molecular imaging; Peptide

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; COPPER NOTA BBN ARGINYLGLYCYLASPARTIC ACID CU 64; DELTA OPIATE RECEPTOR; DIMER; ERYTHROPOIETIN RECEPTOR; FLUORINE FB BBN ARGINYLGLYCYLASPARTIC ACID F 18; FLUORINE FB PEG3 BBN ARGINYLGLYCYLASPARTIC ACID F 18; GALLIUM NOTA BBN ARGINYLGLYCYLASPARTIC ACID GA 68; GASTRIN RELEASING PEPTIDE RECEPTOR; HETERODIMER; HOMODIMER; MELANOCORTIN 4 RECEPTOR; MONOMER; PEPTIDOMIMETIC AGENT; TETRAMER; TETRAXETAN; TRACER; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

BINDING AFFINITY; BREAST CANCER; CANCER CELL; DIMERIZATION; DRUG STRUCTURE; ISOTOPE LABELING; LIGAND BINDING; MOLECULAR IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR BINDING; REVIEW;

ANIMALS; DIMERIZATION; HUMANS; MOLECULAR IMAGING; MOLECULAR PROBES; NEOPLASMS; PEPTIDE HORMONES;

EID: 84855209928     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-010-0546-y     Document Type: Review

References (32)

1. Aloj L, Morelli G (2004) Design, synthesis and preclinical evaluation of radiolabeled peptides for diagnosis and therapy. Curr Pharm Des 10:3009-3031 (Pubitemid 39214008)
2. Benedetti E, Morelli G, Accardo A, Mansi R, Tesauro D, Aloj L (2004) Criteria for the design and biological characterization of radiolabeled peptide-based pharmaceuticals. BioDrugs 18:279-295 (Pubitemid 39381945)
3. Handl HL, Vagner J, Han H, Mash E, Hruby VJ, Gillies RJ (2004) Hitting multiple targets with multimeric ligands. Expert Opin Ther Targets 8:565-586 (Pubitemid 40028367)
4. Josan JS, Vagner J, Handl HL, Sankaranarayanan R, Gillies RJ, Hruby VJ (2008) Solid-phase synthesis of heterobivalent ligands targeted to melanocortin and cholecystokinin receptors. Int J Pept Res Ther 14:293-300
5. Kwekkeboom D, Krenning EP, de Jong M (2000) Peptide receptor imaging and therapy. J Nucl Med 41:1704-1713
6. Li ZB, Cai W, Cao Q et al (2007) (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. J Nucl Med 48:1162-1171 (Pubitemid 47052657)
7. Li ZB, Chen K, Chen X (2008a) (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression. Eur J Nucl Med Mol Imaging 35:1100-1108
8. 18F-labeled BBNRGD heterodimer for prostate cancer imaging. J Nucl Med 49:453-461 (Pubitemid 351355212)
9. Liu S (2006) Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol Pharm 3:472-487 (Pubitemid 44639125)
10. Liu S, Edwards DS, Ziegler MC, Harris AR, Hemingway SJ, Barrett JA (2001) 99mTc-labeling of a hydrazinonicotinamide-conjugated vitronectin receptor antagonist useful for imaging tumors. Bioconjug Chem 12:624-629 (Pubitemid 32696237)
11. Liu Z, Liu S, Wang F, Chen X (2009a) Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers. Eur J Nucl Med Mol Imaging 36:1296-1307
12. Liu Z, Niu G, Shi J, Liu S, Wang F, Chen X (2009b) (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging. Eur J Nucl Med Mol Imaging 36:947-957
13. Liu Z, Yan Y, Chin FT, Wang F, Chen X (2009c) Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FBPEG3-Glu-RGD-BBN. J Med Chem 52:425-432
14. Liu Z, Li ZB, Cao Q, Liu S, Wang F, Chen X (2009d) Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer. J Nucl Med 50:1168-1177
15. Liu Z, Niu G, Wang F, Chen X (2009e) (68)Ga-labeled NOTA-RGDBBN peptide for dual integrin and GRPR-targeted tumor imaging. Eur J Nucl Med Mol Imaging 36:1483-1494
16. Liu Z, Yan Y, Liu S, Wang F, Chen X (2009f) 18F, 64Cu, and 68 Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer. Bioconjug Chem 20:1016-1025
17. Mammen M, Choi S-K, Whitesides G (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem 37:2755-2794
18. Pillai R, Marinelli ER, Swenson RE (2006) A flexible method for preparation of peptide homo- and heterodimers functionalized with affinity probes, chelating ligands, and latent conjugating groups. Biopolymers 84:576-585 (Pubitemid 44935257)
19. Reubi JC, Waser B (2003) Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging 30:781-793 (Pubitemid 36612963)
20. Sharma SD, Jiang J, Hadley ME, Bentley DL, Hruby VJ (1996) Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors. Proc Natl Acad Sci USA 93:13715-13720 (Pubitemid 26424185)
21. Shrivastava A, von Wronski MA, Sato AK et al (2005) A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases. Protein Eng Des Sel 18:417-424 (Pubitemid 41219888)
22. Shrivastava A, Nunn AD, Tweedle MF (2009) Designer peptides: learning from nature. Curr Pharm Des 15:675-681
23. Tweedle MF (2006) Adventures in multivalency, the Harry S. Fischer memorial lecture CMR 2005; Evian, France. Contrast Media Mol Imaging 1:2-9
24. Tweedle MF (2009) Peptide-targeted diagnostics and radiotherapeutics. Acc Chem Res 42:958-968
25. Vadas O, Rose K (2007) Multivalency-a way to enhance binding avidities and bioactivity-preliminary applications to EPO. J Pept Sci 13:581-587 (Pubitemid 47490323)
26. Vagner J, Xu L, Handl HL et al (2008) Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin- 4 and delta-opioid receptors. Angew Chem Int Ed Engl 47:1685-1688
27. Wu Y, Zhang X, Xiong Z et al (2005) microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. J Nucl Med 46:1707-1718 (Pubitemid 46211595)
28. Wu Z, Li ZB, Chen K et al (2007) microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4). J Nucl Med 48:1536-1544 (Pubitemid 47397404)
29. Xu L, Vagner J, Josan J et al (2009) Enhanced targeting with heterobivalent ligands. Mol Cancer Ther 8:2356-2365
30. Ye Y, Bloch S, Xu B, Achilefu S (2006) Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J Med Chem 49:2268-2275
31. Zaccaro L, Del Gatto A, Pedone C, Saviano M (2009) Peptides for tumour therapy and diagnosis: current status and future directions. Curr Med Chem 16:780-795
32. Zhang X, Xiong Z, Wu Y et al (2006) Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. J Nucl Med 47:113-121